UBS Upgrades Medtronic to Buy, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 88.2%

Neg 0% Neu 0% Pos 88.2%

UBS analyst Priya Sachdeva upgrades Medtronic (NYSE:MDT) from Neutral to Buy and raises the price target from $85 to $100.